Allied Health & Imaging · Independent exam preparation
ARDMS Breast (BR): Image Interpretation and Clinical Correlation Study Guide
Practise breast lesion characterization, imaging correlation, scan optimization, and biopsy concordance with a selective guide aligned to ARDMS BR Version 24.1.
By CertMedbry · Updated 30 October 2026
Distinguish cystic from solid findings, recognize suspicious morphology, resolve imaging discrepancies, and select scanning adjustments that improve diagnostic confidence. This guide develops 60 selected concepts for the ARDMS Breast (BR) specialty examination using Version 24.1. The official content outline defines the full examination scope; these concepts provide focused preparation rather than exhaustive coverage.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which examination and certification pathway does this guide address?
This guide addresses the Breast (BR) specialty examination administered by ARDMS, part of Inteleos. BR contributes toward RDMS certification; SPI is also required. The workbook label Breast Sonography Registry Exam refers here to that same BR examination.
Which blueprint applies, and when does it change?
Version 24.1 applies to examinations delivered before December 16, 2026. Its weights are Anatomy and Physiology 15%, Pathology 34%, Integration of Data 19%, Protocols 13%, Ultrasound Physics 12%, and Emerging Technology and Treatment 7%. Its original effective date is not stated in the PDF. Version 26.1 applies on or after December 16, 2026, with Anatomy and Physiology 18%, Pathology 38%, Integration of Data 10%, and Imaging Techniques and Technology 34%.
Breast (BR) — Inteleos · Breast Sonography Examination Content Outline, Version 24.1 · Breast Examination Content Outline, Version 26.1
What practice formats does this guide contain?
The guide contains 20 four-option, single-best-answer questions and 20 flashcards. Question explanations examine the correct response and the alternatives. These independent exercises support learning; they do not establish the official examination's length, item count, delivery format, or passing standard.
How does the guide distribute its concepts across domains?
The concepts comprise 9 Anatomy and Physiology, 20 Pathology, 12 Integration of Data, 8 Protocols, 7 Ultrasound Physics, and 4 Emerging Technology and Treatment concepts. This selective allocation approximates Version 24.1 emphasis. The official outline remains the full examination scope.
How are the practice questions and flashcards distributed?
The questions and flashcards each contain 3 Anatomy and Physiology, 7 Pathology, 4 Integration of Data, 3 Protocols, 2 Ultrasound Physics, and 1 Emerging Technology and Treatment items. Small-set rounding approximates the Version 24.1 domain weights.
Which BI-RADS publication is current?
ACR identifies BI-RADS v2025 as its current breast imaging manual. It standardizes terminology, report organization, assessment, management communication, and outcome monitoring. Apply the current ultrasound terminology and assessment boundaries when reviewing older educational examples.
ACR Breast Imaging Reporting & Data System (BI-RADS®) · BIRADS-v2025-Whats-New.pdf
This independent educational guide develops clinical reasoning through mechanisms, discriminating imaging features, assessment categories, and target correlation. Its questions and flashcards are independently authored learning materials without official endorsement.
Outline used: Version 24.1, applicable on 2026-10-12 for examinations delivered before 2026-12-16. The workbook label 'Breast Sonography (BR) Registry Exam' maps to the official ARDMS Breast (BR) examination; the assigned slug is preserved. Version 26.1 takes effect on 2026-12-16 and is not the blueprint used for this preview. The original effective date of Version 24.1 is not stated in the opened PDF.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Anatomy and Physiology15%
1.Which breast tissue layers establish a reliable scanning map?
A superficial-to-deep survey identifies skin, subcutaneous fat, fibroglandular tissue, retromammary fat, and the pectoral region. These compartments help distinguish a breast lesion from a dermal finding or chest-wall structure. Fibroglandular tissue generally appears brighter than fat, while muscle has a striated appearance. Follow an abnormality through adjacent images to establish its compartment before assigning its origin or measuring it as a discrete mass.
Apply it
For a superficial palpable nodule, use adequate gel and light pressure to show its relationship to the dermis and underlying fat.
Common pitfall: A cropped image can conceal tissue boundaries. A hypoechoic structure beneath the probe is not automatically a parenchymal mass.
Basics of Breast Ultrasound — UCLA Health · Breast US: Guide for Beginners — RadioGraphics, 2025
2.What makes the terminal duct lobular unit clinically important?
The terminal duct lobular unit combines a terminal duct with its associated milk-producing lobules. Lobules produce milk, and ducts convey it toward the nipple. This arrangement provides a functional framework for understanding breast tissue and pathological terminology. Ductal and lobular refer to epithelial structures or pathological patterns; in situ and invasive describe whether abnormal cells remain confined or extend into surrounding tissue. These distinctions answer different anatomical and pathological questions.
Apply it
When a report uses lobular and in situ together, explain the involved epithelial pattern separately from the confinement of abnormal cells.
Common pitfall: An anatomical label does not independently establish invasion, biological aggressiveness, or a characteristic ultrasound appearance.
What Is Breast Cancer? — National Cancer Institute · Breast Sonography Examination Content Outline, Version 24.1
3.How does duct anatomy help identify a tubular structure?
Breast ducts travel toward the nipple and appear tubular when followed longitudinally. In cross-section, the same duct can resemble a small round focus. Rotate the transducer and track continuity toward the nipple to establish its anatomical course. Vessels can also appear tubular, so optimized Doppler provides complementary information. After identifying a duct, assess its walls and contents because ductal continuity does not establish that an associated finding is benign.
Apply it
A round retroareolar focus becomes elongated after rotation. Follow its course and inspect its contents before calling it an isolated cyst.
Common pitfall: Round shape, anechoic contents, or absent displayed flow alone cannot reliably distinguish a duct from every cyst or vessel.
Basics of Breast Ultrasound — UCLA Health · ACR Practice Parameter for the Performance of a Diagnostic Breast Ultrasound Examination, revised 2021
4.How do connective tissue interfaces affect breast images?
Fibrous supporting tissue creates echogenic interfaces within the breast, including Cooper ligaments extending through tissue compartments. These interfaces organize normal anatomy and may produce focal shadowing depending on the beam angle. Recognizing their continuity helps prevent a supporting structure from being mistaken for a discrete mass. Architectural distortion differs because it represents retraction, straightening, or displacement of expected tissue planes rather than merely a bright normal interface.
Apply it
For a shadow beneath a linear echogenic band, sweep through adjacent tissue and change the insonation angle to assess its anatomical continuity.
Common pitfall: Shadowing alone does not prove malignancy. Persistent distortion should also not be dismissed as normal supporting tissue without examining its surrounding architecture.
Basics of Breast Ultrasound — UCLA Health · BI-RADS-Summary-Form-Ultrasound.pdf
5.Why is fat the reference for lesion echogenicity?
Mass echogenicity is described relative to subcutaneous fat. A hypoechoic mass is darker than fat but contains echoes; an isoechoic mass has similar brightness; an anechoic structure has no internal echoes. Fibroglandular tissue is often brighter than fat, so using it as the sole comparator can misclassify a lesion. Echogenicity contributes to characterization but must be integrated with shape, margins, orientation, and associated features because brightness patterns overlap across diseases.
Apply it
A lesion darker than glandular tissue but matching fat should be described as isoechoic to fat, with its other descriptors assessed independently.
Common pitfall: Being dark relative to glandular tissue does not establish hypoechogenicity, and hypoechogenicity alone does not establish malignancy.
Basics of Breast Ultrasound — UCLA Health · BI-RADS-Summary-Form-Ultrasound.pdf
6.How do age and hormones change expected breast composition?
Breast composition changes with age and hormonal exposure. Younger or hormonally stimulated breasts may contain more prominent glandular tissue, whereas involution commonly increases the relative amount of fat. These changes alter background echotexture and the contrast against which abnormalities are detected. Interpret the background alongside physiological history and prior imaging, while assessing each focal finding separately. An age-appropriate tissue pattern explains composition but does not independently explain a new mass.
Apply it
Recognize predominantly fatty tissue as compatible with involution while fully characterizing a new focal mass within that background.
Common pitfall: Expected age-related composition is contextual information. It cannot justify dismissing a focal abnormality or replacing comparison with prior examinations.
7.Why does lactation require both physiological context and focal assessment?
Lactation activates milk production in lobules and transport through ducts. On ultrasound, lactating breast tissue commonly becomes diffusely echogenic, with prominent milk-containing ducts. These widespread changes provide the expected physiological background against which a focal finding must be assessed. A discrete mass, localized collection, or focal architectural distortion requires separate characterization rather than being attributed to generalized lactational change. Evaluate the finding's shape, margins, orientation, internal echoes, posterior acoustic features, and vascularity, and establish whether it corresponds to the patient's localized symptom.
Apply it
In a breastfeeding patient with a persistent lump, distinguish the diffuse echogenic parenchyma and prominent ducts from the finding at the exact palpable site. For example, an irregular focal mass remains a separate abnormality even when the surrounding tissue has an expected lactational appearance.
Common pitfall: Prominent ducts and diffuse echogenicity can reflect normal lactation; they do not establish that a focal lump is physiological. Conversely, background echogenicity alone should not be interpreted as a focal solid lesion.
What Is Breast Cancer? — National Cancer Institute · Breast Ultrasound — RadiologyInfo · Basics of Breast Ultrasound — UCLA Health
8.Which features characterize a typical benign axillary node?
A typical benign axillary node is oval or gently lobulated, retains an echogenic fatty hilum, and has a thin, relatively uniform cortex. Cortical thickness below 3 mm is a commonly used morphological reference in the cited teaching resource. Overall size alone is less discriminating than architecture. Evaluate cortical thickness and distribution together with hilar preservation, since an enlarged node may retain benign morphology while a smaller node may show suspicious structural change.
Apply it
Describe the preserved architecture of a long oval node with a uniform 2 mm cortex rather than declaring metastasis from its length.
Common pitfall: Benign morphology does not establish a specific reactive cause. Morphological description and clinical explanation remain separate judgments.
9.Which regional lymph-node locations matter in breast evaluation?
Regional groups include axillary, internal mammary, and supraclavicular nodes. Axillary levels use pectoralis minor as their landmark: level I lies lateral to its lateral margin, level II lies posterior to it and includes interpectoral nodes, and level III lies medial to its medial margin. Intramammary nodes lie within breast tissue, commonly in the upper outer breast or axillary tail. Location identifies the station, whereas cortical and hilar morphology characterize its appearance.
Apply it
Identify a node posterior to pectoralis minor as level II, then separately document its cortex, shape, and fatty hilum.
Common pitfall: A nodal level is an anatomical position rather than a grade of suspicion or proof of metastatic involvement.
Breast Anatomy — NCI SEER Training · BI-RADS-Summary-Form-Ultrasound.pdf
Pathology34%
10.Which combined criteria establish a simple breast cyst?
The current ACR description includes round or oval shape, circumscribed margins, anechoic contents, and a thin wall. Posterior enhancement often supports the diagnosis but need not be conspicuous in every simple cyst. Confirm the shape, wall, and contents with technically adequate multiplanar imaging and appropriate gain. A true solid component prevents simple-cyst classification. Accreditation requirements for submitted cyst examples should be distinguished from the clinical description of a simple cyst.
Apply it
Assess all structural criteria in an anechoic oval lesion rather than rejecting the diagnosis solely because enhancement is subtle.
Common pitfall: Enhancement alone cannot establish a simple cyst. Artificially reducing gain can conceal internal tissue and create a false anechoic appearance.
BI-RADS-Summary-Form-Ultrasound.pdf · Clinical Testing: Breast Ultrasound, revised March 13, 2026
11.How does mobile debris differ from a solid cyst component?
Low-level echoes within a fluid-containing lesion may represent debris rather than solid tissue. A dependent layer or material that shifts with repositioning supports suspended contents. An attached component requires separate assessment, especially when internal flow is demonstrated. Absence of displayed flow does not prove debris because small vessels, slow flow, or compression may limit detection. Integrate mobility, wall attachment, morphology, and technically optimized Doppler rather than using any single feature as the deciding test.
Apply it
After repositioning, document echoes settling dependently and confirm that no persistent attached nodule remains.
Common pitfall: Not every internal echo is a solid nodule, and not every avascular-appearing focus is debris. Fixed attachment remains relevant even without detectable flow.
Cystic Lesions of the Breast: Sonographic-Pathologic Correlation — Radiology, 2003 · BI-RADS-Summary-Form-Ultrasound.pdf
12.Why does a mixed solid and cystic mass require separate evaluation?
A lesion containing true solid tissue and fluid differs from a simple cyst or a complicated cyst containing debris. The current echo-pattern term is mixed solid and cystic; older resources may use complex cystic and solid. An attached nodule or other definite solid component requires characterization of its morphology and perfusion. Surrounding fluid does not neutralize the significance of the tissue. Procedural planning must address the solid component if representative tissue sampling is required.
Apply it
Preserve grayscale and Doppler images of a vascular mural nodule, including its attachment and relationship to the surrounding fluid.
Common pitfall: Calling the entire finding a cyst obscures the important tissue component. Aspirating fluid alone may leave that component unsampled.
Cystic Lesions of the Breast: Sonographic-Pathologic Correlation — Radiology, 2003 · Ultrasound-Guided Breast Biopsy — RadiologyInfo · BI-RADS-Summary-Form-Ultrasound.pdf
13.Which pattern supports fibroadenoma without proving its histology?
Fibroadenomas are benign solid tumors that commonly present as mobile lumps. An oval, circumscribed, parallel mass can support a benign interpretation in an appropriate clinical setting. Those descriptors indicate an imaging pattern rather than a confirmed tissue diagnosis. Inspect the full margin and all relevant planes, and integrate symptoms, age, prior studies, and interval change. A familiar appearance should not override a non-circumscribed segment or an unresolved clinical discrepancy.
Apply it
For a mobile lump with benign-appearing morphology, document the complete mass and prior comparison before assessment and management are assigned.
Common pitfall: A presumed fibroadenoma remains an imaging impression unless tissue confirms it. New suspicious morphology or meaningful change requires reassessment.
Benign and Precancerous Breast Lumps and Conditions — National Cancer Institute · Ultrasound: Masses — UCLA Health
14.Why can fat necrosis imitate breast malignancy?
Fat necrosis results from injury to breast fat, including surgical or nonsurgical trauma. Its appearance varies as tissue injury, inflammation, and fibrosis evolve, so it can produce a benign-appearing finding or mimic a suspicious mass. A matching history supports the explanation but does not establish it independently. Correlate the precise site, timing, sonographic morphology, mammographic findings, and evolution before deciding whether fat necrosis adequately explains the abnormality.
Apply it
For a firm postoperative lump, obtain the procedure date and location and compare both mammographic and ultrasound findings.
Common pitfall: A trauma history is not proof of benignity. A location or morphology that does not fit the proposed injury requires separate assessment.
Benign and Precancerous Breast Lumps and Conditions — National Cancer Institute · BI-RADS-Summary-Form-Ultrasound.pdf
15.How can an intraductal papilloma relate to nipple discharge?
An intraductal papilloma is a benign growth within a milk duct and can cause nipple discharge, including bloody discharge. Ultrasound may reveal an intraductal solid component, but neither discharge color nor a ductal location establishes papilloma histology. Assess whether discharge is spontaneous, unilateral, or associated with one duct, and examine the retroareolar system for an attached finding. Describe any identified tissue by its morphology and vascularity rather than presuming it is harmless duct contents.
Apply it
For spontaneous single-duct discharge, document the relevant duct and any attached component in complementary planes.
Common pitfall: Papilloma is one possible cause. Failure to identify a mass does not resolve a clinically concerning discharge pattern.
Benign and Precancerous Breast Lumps and Conditions — National Cancer Institute · ACR Practice Parameter for the Performance of a Diagnostic Breast Ultrasound Examination, revised 2021
16.What does atypical hyperplasia mean when ultrasound is nonspecific?
Atypical hyperplasia is an abnormal proliferation of breast epithelial cells with atypical microscopic features and is associated with increased breast cancer risk. It is a pathological diagnosis rather than a uniquely recognizable sonographic pattern. Reassuring or nonspecific ultrasound cannot independently confirm or invalidate it. After sampling, assess whether the intended target was obtained and whether the pathology and complete imaging findings explain one another, including any target established by mammography.
Apply it
When atypia follows biopsy of a mammographic target, review target documentation and correlation instead of seeking a diagnostic ultrasound appearance of atypical cells.
Common pitfall: Atypia is not synonymous with invasive carcinoma. Its management cannot be determined from ultrasound brightness or the absence of suspicious orientation alone.
Benign and Precancerous Breast Lumps and Conditions — National Cancer Institute · Quality Assurance: Breast Ultrasound, revised November 18, 2024
17.What distinguishes ductal carcinoma in situ from invasive disease?
Ductal carcinoma in situ involves abnormal malignant cells confined within breast ducts. Invasive carcinoma extends into surrounding breast tissue. This distinction concerns microscopic behavior and cannot be established from a mass's size, apparent boundary, or posterior features alone. Ultrasound can characterize a finding and guide sampling, while mammography may demonstrate abnormalities without a sonographic mass. The absence of a discrete ultrasound mass therefore does not establish the absence of clinically important ductal disease.
Apply it
Separate a small mass's imaging description from the tissue evidence required to determine whether disease is in situ or invasive.
Common pitfall: Circumscribed appearance does not prove microscopic confinement. Negative targeted ultrasound cannot independently clear suspicious mammographic calcifications.
What Is Breast Cancer? — National Cancer Institute · Breast Ultrasound — RadiologyInfo · BI-RADS-Summary-Form-Ultrasound.pdf
18.Which mass margins raise concern for tissue infiltration?
A circumscribed margin requires a sharp boundary around the entire mass. Any indistinct, angular, microlobulated, or spiculated portion makes the margin non-circumscribed. These patterns can reflect interaction with surrounding tissue, including infiltration or fibrosis, and require integrated assessment. Inspect the full circumference in multiple planes because a mostly smooth mass can contain an important suspicious segment. Microlobulated describes small margin undulations, whereas lobulated describes overall shape in the current ultrasound lexicon.
Apply it
Save a persistent angular segment even when the remaining boundary is smooth, and describe the non-circumscribed portion accurately.
Common pitfall: Do not average the boundary into a reassuring description. Postoperative fibrosis can also create suspicious-looking margins, making correlation essential.
Ultrasound: Masses — UCLA Health · BI-RADS-Summary-Form-Ultrasound.pdf
19.How is non-parallel orientation determined?
Orientation compares the mass's horizontal and anteroposterior dimensions relative to the skin plane. Parallel orientation requires the horizontal dimension to exceed the anteroposterior dimension in all ultrasound orientations. Non-parallel applies when the anteroposterior dimension equals or exceeds the horizontal dimension in any orientation. This descriptor can increase concern but does not establish histology. Confirm acquisition quality and assess orientation with margins, shape, and associated changes rather than treating one dimension as a complete diagnosis.
Apply it
Recognize non-parallel orientation when one adequate view shows equal horizontal and anteroposterior dimensions, despite a wider-than-tall appearance elsewhere.
Common pitfall: One reassuring plane cannot establish parallel orientation. Oblique imaging and deformation can distort apparent proportions.
20.How should ductal and lobular invasive diagnoses relate to ultrasound descriptors?
Invasive ductal and invasive lobular carcinoma are pathological diagnoses describing invasive breast cancer with different epithelial patterns. Ultrasound descriptors instead report observable shape, margins, orientation, echo pattern, posterior features, and associated tissue changes. These two kinds of information should be correlated without being treated as interchangeable. A suspicious mass or reproducible non-mass abnormality can warrant evaluation even when its appearance does not identify a particular histological subtype. Tissue examination establishes the pathological diagnosis.
Apply it
For persistent distortion without a discrete mass, document the abnormal architecture and correlate other imaging rather than requiring a stereotyped mass appearance.
Common pitfall: Shadowing cannot reliably assign ductal versus lobular histology. A mass-only search can overlook a meaningful non-mass finding.
What Is Breast Cancer? — National Cancer Institute · Breast Sonography Examination Content Outline, Version 24.1 · BI-RADS-Summary-Form-Ultrasound.pdf
21.What can lesion vascularity establish?
Doppler can demonstrate moving blood within or around a finding, adding evidence about perfused tissue. Reproducible internal flow supports a solid component rather than simple fluid, but does not independently establish malignancy because benign lesions and inflammation may also show flow. Absent displayed flow is limited by vessel size, velocity, pressure, and settings. Describe the vascular pattern alongside grayscale morphology and confirm technical adequacy before allowing a negative Doppler observation to influence interpretation.
Apply it
If a presumed debris focus contains reproducible internal flow, reassess its attachment and morphology as a possible solid component.
Common pitfall: Abundant flow is not a cancer diagnosis, and absent flow is not proof of benignity or fluid composition.
ACR Practice Parameter for the Performance of a Diagnostic Breast Ultrasound Examination, revised 2021 · Cystic Lesions of the Breast: Sonographic-Pathologic Correlation — Radiology, 2003
22.Which findings support an abscess rather than uncomplicated fluid?
An abscess is an infected collection that may contain debris and show surrounding inflammatory change. Pain, erythema, swelling, and a compatible clinical course strengthen that interpretation. Ultrasound may demonstrate a complicated collection with surrounding hyperemia, while an uncomplicated postoperative collection generally lacks those combined inflammatory findings. Evaluate the collection and adjacent tissue together because seroma, hematoma, and infection can overlap in internal appearance. Clinical agreement provides information that debris alone cannot supply.
Apply it
Document the extent, contents, and surrounding hyperemia of a postoperative collection in a patient with worsening redness and tenderness.
Common pitfall: Blood products can also produce debris. Conversely, a relatively simple-looking fluid center does not exclude infection in a convincing clinical setting.
Post-Surgical Fluid Collections: Causes, Symptoms, and Management — UCLA Health
23.Why can apparently reassuring features fail to exclude malignancy?
Oval shape, a largely smooth contour, or posterior enhancement cannot independently establish benign histology. A solid mass must be assessed using its entire morphology, clinical context, and interval comparison. The official outline includes named malignant processes such as medullary malignancy, but a subtype cannot be assigned from one acoustic feature. Enhancement describes sound transmission, and a smooth-appearing segment describes only that part of the boundary. Neither substitutes for complete characterization or tissue diagnosis when indicated.
Apply it
Examine every margin segment of a new enhancing solid mass before interpreting its overall appearance as reassuring.
Common pitfall: Do not use a familiar benign-looking feature to cancel a persistent suspicious finding or to assign a specific malignant subtype.
Breast Sonography Examination Content Outline, Version 24.1 · Ultrasound: Masses — UCLA Health · BI-RADS-Summary-Form-Ultrasound.pdf
24.How do postoperative seroma and hematoma differ?
A seroma contains serous fluid in a surgical space and may be anechoic or contain septations and debris. A hematoma contains blood and changes appearance as clot forms and breaks down. Recent biopsy, trauma, and bruising support hematoma, whereas a smooth avascular cavity collection can support seroma. Their appearances overlap, so integrate timing, location, symptoms, perfusion, and evolution. Increasing erythema, pain, or surrounding hyperemia raises concern that a collection may be infected.
Apply it
Compare a bruised collection along a recent needle path with a painless smooth collection in a lumpectomy cavity, documenting each finding's contents and dimensions.
Common pitfall: Neither collection has one mandatory echo pattern. A new vascular component should not be assumed to represent routine postoperative fluid.
Post-Surgical Fluid Collections: Causes, Symptoms, and Management — UCLA Health · BI-RADS-Summary-Form-Ultrasound.pdf
26.What distinguishes intracapsular from extracapsular silicone rupture?
A fibrous capsule forms around an implant and is anatomically distinct from the manufactured implant shell. Intracapsular silicone rupture means silicone escapes the shell but remains contained within that fibrous capsule. Extracapsular rupture means silicone extends beyond the capsule into surrounding tissue. Identify the boundary crossed before assigning the term. Implant filling and clinical presentation also matter because saline deflation and silicone leakage do not necessarily produce the same visible change.
Apply it
Classify silicone outside the shell but contained within the surrounding capsule as intracapsular rupture.
Common pitfall: Intracapsular does not mean an intact implant shell. Confusing shell and capsule reverses the relevant anatomical distinction.
27.Which distribution supports gynecomastia?
Gynecomastia is proliferation of male breast glandular tissue, typically centered directly beneath the nipple. It may have a nodular or flame-shaped retroareolar distribution. This central relationship helps distinguish a typical presentation from a separate eccentric mass requiring its own assessment. Tenderness and medication history provide context but do not establish the diagnosis independently. Evaluate tissue distribution and any focal abnormality together, including suspicious skin findings or a palpable area that imaging has not explained.
Apply it
Confirm that tender tissue is centered behind the nipple and assess for a separate eccentric mass before assigning a unified explanation.
Common pitfall: Male breast symptoms are not automatically gynecomastia. A discordant palpable finding deserves targeted evaluation even when retroareolar glandular tissue is present.
28.Which nodal changes are more concerning than enlargement alone?
Suspicious nodal morphology includes cortical thickening, increasingly rounded shape, and loss or replacement of the fatty hilum. Cortical thickening can be an early but nonspecific change, while hilar replacement is more concerning. Reactive conditions can also alter nodes, so integrate laterality, clinical history, and breast findings. Describe focal versus uniform cortical change and hilar preservation directly rather than substituting a size label for architectural assessment. Morphological concern still requires correlation rather than automatic assignment of metastasis.
Apply it
Between equally long nodes, identify the rounded node with hilar replacement as more concerning than one retaining a thin cortex and fatty hilum.
Common pitfall: A normal-sized node can be suspicious, and cortical thickening alone does not prove metastatic disease.
29.Why can edema and skin change have competing explanations?
Breast edema and skin thickening may occur with inflammation, treatment effects, or malignant disease. Ultrasound edema appears as interconnected hypoechoic or anechoic lines representing interstitial fluid or dilated lymphatics. A painful collection with surrounding hyperemia supports abscess in the appropriate setting, but diffuse changes without a collection remain unexplained by that pattern. Evaluate skin, underlying tissue, and regional nodes, and integrate the clinical course. Absence of a discrete mass does not establish a benign explanation.
Apply it
Document persistent diffuse thickening and redness even when no drainable collection or discrete mass is identified.
Common pitfall: Redness alone does not establish infection. A negative mass search cannot resolve persistent unexplained inflammatory-appearing clinical changes.
What Is Breast Cancer? — National Cancer Institute · Post-Surgical Fluid Collections: Causes, Symptoms, and Management — UCLA Health · BI-RADS-Summary-Form-Ultrasound.pdf
41.How do BI-RADS categories connect risk and management?
Category 0 is incomplete and requires additional imaging or prior comparison. Category 1 is negative and category 2 is benign; both carry essentially 0% malignancy likelihood and routine screening management. Category 3 is probably benign, with greater than 0% but no more than 2% malignancy likelihood: initial short-interval follow-up is at 6 months, while continued surveillance may use a 12-month interval when appropriate to the follow-up stage. Category 4 is suspicious, greater than 2% but below 95%, and requires tissue diagnosis. Category 5 is at least 95% and also requires tissue diagnosis. Category 6 denotes known biopsy-proven malignancy.
Apply it
A newly assigned category 3 finding receives an initial 6-month follow-up recommendation. A stable finding already undergoing surveillance may appropriately receive a 12-month surveillance interval at a later stage. A completely assessed finding estimated at 10% malignancy likelihood belongs in category 4 and requires tissue diagnosis.
Common pitfall: Do not substitute a 12-month surveillance interval for the initial 6-month category 3 follow-up. Category 3 requires a completed assessment; it does not resolve category 0. Category 6 indicates established malignancy rather than an imaging probability exceeding category 5.
Integration of Data19%
25.How should prior imaging guide assessment of a surgical scar?
Surgery can produce distortion, shadowing, fluid collections, and fat necrosis, overlapping findings that may also require evaluation for new disease. Interpretation depends on the operative site, procedure, treatment timing, and prior imaging. A new discrete mass or progressive unexplained change should be characterized separately from an established scar pattern. Ultrasound defines morphology and location, while comparison with mammography and clinical findings helps determine whether the abnormality fits the expected treatment history.
Apply it
Image a newly palpable nodule at a scar edge separately from previously stable linear shadowing and document the difference.
Common pitfall: At the scar describes a location, not a complete diagnosis. Stability of one postoperative feature does not establish stability of a neighboring new finding.
Benign and Precancerous Breast Lumps and Conditions — National Cancer Institute · Post-Surgical Fluid Collections: Causes, Symptoms, and Management — UCLA Health · Breast Ultrasound — RadiologyInfo
30.How is a mammographic target translated into a sonographic search?
Mammography provides target location, depth, and morphology to guide ultrasound. Different positioning between compressed mammography and ultrasound means that clockface position alone may not establish correspondence. Integrate laterality, quadrant, nipple distance, tissue depth, nearby landmarks, size, and appearance. A credible correlate should plausibly explain the original abnormality. Finding an incidental lesion near the anticipated location does not demonstrate that the mammographic target has been evaluated or provide an automatic substitute for targeting.
Apply it
Compare a posterior mammographic mass with the depth and morphology of an ultrasound finding before accepting a nearby superficial cyst as its correlate.
Common pitfall: Geographic proximity alone is insufficient. A convenient sonographic finding can be unrelated to the abnormality that prompted scanning.
ACR Practice Parameter for the Performance of a Diagnostic Breast Ultrasound Examination, revised 2021 · Breast Ultrasound — RadiologyInfo
31.Why does mammography remain essential for calcifications?
Ultrasound may show calcifications as echogenic foci, particularly within a hypoechoic mass, non-mass lesion, or duct. Their morphology is less readily characterized than on mammography, so mammographic correlation is required for precise analysis. A negative ultrasound does not negate suspicious mammographic morphology or distribution. If a sonographic finding is proposed for sampling, its correspondence to the calcification target must be established; brightness alone cannot prove that the intended deposits have been located.
Apply it
Maintain the evaluation of suspicious grouped mammographic calcifications when ultrasound shows no definite correlate.
Common pitfall: Neither absent sonographic foci nor an unrelated bright focus clears the original target. Guidance must address the actual abnormality.
Ultrasound: Calcifications — UCLA Health · BI-RADS-Summary-Form-Ultrasound.pdf
32.How should ultrasound address mammographic distortion without a mass?
A mammographic abnormality may represent altered architecture rather than a discrete space-occupying mass. Targeted ultrasound should therefore examine tissue alignment, focal retraction, persistent shadowing, and non-mass changes as well as measurable masses. Current terminology recognizes a non-mass lesion as a reproducible three-dimensional finding lacking the discrete margins and assignable shape of a mass. If ultrasound provides no convincing correlate, the original mammographic concern remains unresolved rather than automatically becoming benign.
Apply it
At the site of mammographic distortion, assess tissue planes and reproducible shadowing instead of ending the examination when no oval mass appears.
Common pitfall: A mass-only search can miss the relevant pattern. Failure to find a correlate does not invalidate the other modality's abnormality.
ACR Practice Parameter for the Performance of a Diagnostic Breast Ultrasound Examination, revised 2021 · BI-RADS-Summary-Form-Ultrasound.pdf
33.How does second-look ultrasound evaluate an MRI finding?
Second-look ultrasound searches for a sonographic correlate to an MRI-detected abnormality. MRI and ultrasound differ in positioning and image contrast, so correspondence depends on depth, landmarks, size, location, and appearance rather than a shared clockface coordinate alone. A convincing sonographic correlate may permit ultrasound-guided sampling. Before substituting guidance methods, establish that the ultrasound finding plausibly represents the MRI target. A separate incidental mass does not resolve the original enhancing abnormality.
Apply it
Compare a superficial ultrasound mass with the depth and landmarks of a posterior MRI lesion before accepting it as the biopsy target.
Common pitfall: The easiest visible lesion to sample may be unrelated. Target correspondence must precede selection of a convenient guidance method.
MR-Guided Breast Biopsy — RadiologyInfo · ACR Practice Parameter for the Performance of a Diagnostic Breast Ultrasound Examination, revised 2021
34.When does a suspicious MRI-only finding require MRI-guided targeting?
A suspicious MRI finding may have no reliable mammographic or sonographic correlate. When tissue sampling is indicated and the target remains visible only on MRI, MRI-guided biopsy addresses it using the modality that demonstrates it. Ultrasound cannot reliably guide a needle into a target it has not identified. Guidance selection therefore follows target visibility and correspondence. Negative second-look ultrasound does not independently reduce the significance of an enhancing lesion already assessed as suspicious.
Apply it
Preserve the MRI-guided evaluation pathway when careful ultrasound fails to identify a matching target suitable for sampling.
Common pitfall: A nearby ultrasound-visible lesion is not a valid substitute without correspondence, and a clockface coordinate alone does not create a mammographic target.
MR-Guided Breast Biopsy — RadiologyInfo · Ultrasound-Guided Breast Biopsy — RadiologyInfo
35.Why can a suspicious palpable lump outweigh reassuring imaging?
Clinical and imaging findings must agree at the actual site of concern. A persistent clinically suspicious palpable abnormality is not explained by a normal ultrasound or a benign lesion elsewhere. Confirm the exact site, correlate the physical examination with relevant imaging, and communicate any unresolved discrepancy. Additional assessment, including tissue sampling when appropriate, may be needed despite reassuring images because an absent imaging correlate does not establish the cause of a concerning palpable finding.
Apply it
Return to a firm fixed lump when the scan documents only a simple cyst several centimeters away.
Common pitfall: A benign incidental finding should not close an unrelated clinical problem. Sharing a quadrant is insufficient to establish that it explains the lump.
36.What makes a benign biopsy result imaging-pathology discordant?
Imaging-pathology concordance asks whether the tissue diagnosis plausibly explains the intended imaging target. Normal adipose tissue does not adequately explain a suspicious spiculated mass, so that benign result is discordant. Review target identity, needle position, sampling documentation, and pathology together to assess targeting and sampling adequacy. Communicate and document the discrepancy. Persistent discordance requires additional tissue evaluation through repeat percutaneous biopsy or surgical excision, with the approach selected after this review. A technically completed biopsy and benign pathology wording do not independently establish representative sampling.
Apply it
For a spiculated mass yielding only normal adipose tissue, compare the biopsy images with the original target and discuss the mismatch with the interpreting radiologist and pathologist. If discordance persists, arrange repeat percutaneous sampling or surgical excision rather than accepting the result as a concordant benign diagnosis.
Common pitfall: A marker documents a sampled location but cannot prove that representative tissue was obtained. Routine imaging surveillance alone does not resolve persistent discordance between a suspicious target and nonspecific benign tissue.
Quality Assurance: Breast Ultrasound, revised November 18, 2024 · Ultrasound-Guided Breast Biopsy — RadiologyInfo · asbrs-ccs-image-guided-biopsy.pdf
37.How does procedural documentation support target confirmation?
A biopsy record should connect the preprocedure lesion, its location, needle position, sampling, and any marker placement to the same target. This sequence supports later imaging-pathology correlation and allows another clinician to identify the sampled finding. Marker placement documents a site but does not independently prove representative sampling. When target identity is uncertain, compare the original lesion labels, procedural images, device position, and subsequent imaging rather than relying on the presence of a marker alone.
Apply it
If two neighboring lesions were present, reconstruct which was sampled using their individual locations and needle documentation.
Common pitfall: Target identity, representative tissue acquisition, and a pathology result that explains the finding are related but separate requirements.
Ultrasound-Guided Breast Biopsy — RadiologyInfo · Quality Assurance: Breast Ultrasound, revised November 18, 2024
38.Which history details materially change ultrasound interpretation?
Relevant history includes the exact symptom and location, onset, pregnancy or lactation, procedures, cancer treatment, medications, and pertinent personal or family history. These details help select the region to examine and test possible explanations. Recent biopsy can support a hematoma, while surgery can explain established scar-related change. History must match the timing, location, and morphology of the observed finding. It provides context rather than permission to overlook an abnormality that does not fit.
Apply it
For a collection near a lump, compare recent procedure details with the collection's site and appearance before assigning a postprocedural cause.
Common pitfall: Obtaining history without applying it adds little. A compelling explanation remains inadequate when its predicted location or course differs from the actual finding.
ACR Practice Parameter for the Performance of a Diagnostic Breast Ultrasound Examination, revised 2021 · Post-Surgical Fluid Collections: Causes, Symptoms, and Management — UCLA Health
39.How should nipple discharge be characterized before scanning?
Clarify whether discharge is spontaneous or expressed, unilateral or bilateral, and associated with one duct or several. Color and accompanying lumps or skin changes add context. These characteristics help determine whether a focal ductal process is plausible and direct retroareolar evaluation. A clinically concerning pattern remains relevant even when ultrasound identifies no lesion. Imaging should be interpreted against the actual presentation rather than treating an unremarkable duct survey as a complete explanation of the symptom.
Apply it
Before scanning reported nipple fluid, establish spontaneity, laterality, the involved opening, and any associated focal symptom.
Common pitfall: Color alone cannot establish the cause. Negative ultrasound does not independently resolve persistent concerning spontaneous single-duct discharge.
ACR Practice Parameter for the Performance of a Diagnostic Breast Ultrasound Examination, revised 2021 · Benign and Precancerous Breast Lumps and Conditions — National Cancer Institute
40.How can serial imaging distinguish true change from measurement variation?
Interval comparison requires confirmation that the same lesion was examined with comparable planes, boundaries, and compression. Different probe angles or caliper placement can create apparent dimensional change. Compare morphology as well as numbers because a new angular margin or non-parallel orientation can matter even when size is similar. Document technical differences that limit interpretation. Stability or growth should describe a defensible comparison of the same finding rather than unmatched images with superficially similar labels.
Apply it
Reproduce an earlier imaging plane before interpreting a small size difference seen on a more oblique or less compressed follow-up view.
Common pitfall: Numerical increase is not automatically growth, and unchanged dimensions do not establish unchanged morphology.
ACR Practice Parameter for the Performance of a Diagnostic Breast Ultrasound Examination, revised 2021 · Ultrasound: Masses — UCLA Health
Protocols13%
42.How does positioning improve access to breast tissue?
Position the patient to spread the tissue of interest over the chest wall and permit stable contact without excessive compression. Supine positioning may suit medial tissue, while an oblique position can improve lateral access by reducing tissue thickness. The appropriate position depends on target location and body habitus. Reposition when needed to follow a palpable finding, expose a posterior target, or improve tissue contact before assuming that poor visualization is an unavoidable equipment limitation.
Apply it
Turn a patient obliquely when lateral tissue remains thick and a deep target is poorly defined in the fully supine position.
Common pitfall: An inflexible posture can impair resolution or encourage excessive pressure. Positioning should support visualization of the actual target.
Breast US: Guide for Beginners — RadioGraphics, 2025 · ACR Practice Parameter for the Performance of a Diagnostic Breast Ultrasound Examination, revised 2021
43.Why are orthogonal images necessary?
Orthogonal images show the same finding in perpendicular planes and reduce the chance that one favorable slice conceals its shape, margin, or orientation. A duct can appear round in cross-section, and a suspicious margin segment may be visible only after rotation. Sweep through the entire finding before selecting representative views. Two-dimensional ultrasound should demonstrate a mass in two different planes, while static documentation supports rather than replaces complete real-time assessment of its extent.
Apply it
Rotate through a smooth round focus to establish whether it is a discrete mass or the cross-section of a continuous tubular structure.
Common pitfall: Two saved images are not necessarily orthogonal. Near-duplicate slices may omit the feature needed for accurate characterization.
ACR Practice Parameter for the Performance of a Diagnostic Breast Ultrasound Examination, revised 2021 · BI-RADS-Summary-Form-Ultrasound.pdf
44.When are radial and antiradial planes especially useful?
Radial scanning aligns the imaging plane with the direction toward the nipple, while antiradial scanning crosses that orientation. These complementary approaches help demonstrate duct continuity, intraductal findings, and a lesion's relationship to the nipple. They supplement longitudinal and transverse approaches rather than replacing full lesion assessment. Choose and label planes deliberately so another examiner can distinguish a view following ductal anatomy from one crossing it and can reproduce the examination meaningfully.
Apply it
Follow a suspected intraductal component radially toward the nipple, then examine its cross-section and attachment in an antiradial view.
Common pitfall: Radial does not mean any oblique probe position. Its meaning depends on the relationship to the nipple and breast anatomy.
ACR Practice Parameter for the Performance of a Diagnostic Breast Ultrasound Examination, revised 2021 · Basics of Breast Ultrasound — UCLA Health
45.How can a gel standoff improve superficial imaging?
Generous gel or a standoff pad separates the transducer face from a very superficial target, improving near-field access while reducing the need to flatten it. This technique helps show superficial walls, skin involvement, and the relationship between a small finding and the dermis. Combine the standoff with light pressure, suitable frequency, focus, and gain. The objective is improved visualization of the original anatomy rather than greater compression or enlargement of an already distorted image.
Apply it
Add gel and lighten contact when a tiny palpable nodule becomes difficult to see under routine pressure.
Common pitfall: Pressing harder may deform or obscure the target. Changing focus alone does not correct excessive mechanical compression.
Equipment: Breast Ultrasound, revised January 2, 2026 · ACR Practice Parameter for the Performance of a Diagnostic Breast Ultrasound Examination, revised 2021
46.Which location labels make a finding reproducible?
A reproducible location includes laterality, clockface position, and nipple distance, with depth and image orientation as appropriate. The current ACR ultrasound summary measures distance from the nipple base to the center of the finding. Individual identifiers distinguish nearby lesions and support follow-up or intervention. Keep the labels consistent across grayscale, Doppler, measurements, and procedural images so that different observations can be linked confidently to the same target rather than inferred from appearance alone.
Apply it
Assign separate clockface and nipple-distance labels to two masses in one quadrant and retain those identifiers on every relevant image.
Common pitfall: A quadrant may be too broad for neighboring findings. Inconsistent labels can misdirect follow-up, comparison, or biopsy planning.
ACR Practice Parameter for the Performance of a Diagnostic Breast Ultrasound Examination, revised 2021 · BI-RADS-Summary-Form-Ultrasound.pdf
47.How should calipers capture a lesion's dimensions?
Measure the actual lesion boundaries in appropriate orthogonal planes, documenting its greatest dimension and perpendicular dimensions as required by the examination protocol. Exclude posterior shadowing and unrelated surrounding tissue. Obtain comparable planes for follow-up and avoid compression that meaningfully changes shape. Correct measurement begins with identifying the lesion boundary and axes; precise numerical readouts cannot correct an oblique acquisition or a caliper placed on an acoustic effect rather than the lesion itself.
Apply it
For a shadowing mass, place calipers on the visible mass and obtain perpendicular dimensions without including the shadowing column.
Common pitfall: Including shadowing exaggerates size, while measuring only the clearest central portion can underestimate the finding's true extent.
ACR Practice Parameter for the Performance of a Diagnostic Breast Ultrasound Examination, revised 2021 · Clinical Testing: Breast Ultrasound, revised March 13, 2026
48.How should palpation guide targeted ultrasound?
Establish the exact symptomatic site before scanning, ideally with the patient identifying it and the examiner confirming the location. Relate palpation to the tissue beneath the transducer and examine the region thoroughly enough to identify a convincing correlate or document none. A nearby lesion must be shown to correspond to the actual lump. Clear documentation of the scanned site supports clinical-imaging correlation and prevents a referral coordinate or incidental finding from replacing the true target.
Apply it
When the patient's indicated lump differs from the referral diagram, confirm and document both locations and evaluate the actual palpable tissue.
Common pitfall: Scanning only an approximate referral coordinate can miss the concern. A nearby benign lesion is not automatically the palpable correlate.
ACR Practice Parameter for the Performance of a Diagnostic Breast Ultrasound Examination, revised 2021 · Palpable Lump — UCLA Health
49.How can technique reduce retroareolar obscuration?
Nipple contour, acoustic interfaces, and imperfect contact can obscure underlying tissue through shadowing. Use sufficient gel, adjust transducer angle, and approach from adjacent directions to improve the view. Once contact is adequate, radial and antiradial planes help trace the ducts. A symptom-directed examination requires adequate assessment of the retroareolar region, not merely an unsuccessful view through nipple shadowing. Document a limitation when it persists so the absence of a visible lesion is interpreted appropriately.
Apply it
For discharge evaluation, angle the transducer from adjacent tissue and obtain complementary views before judging the underlying ducts.
Common pitfall: No lesion seen through an obscured region does not equal a technically adequate negative examination of that region.
ACR Practice Parameter for the Performance of a Diagnostic Breast Ultrasound Examination, revised 2021 · Breast US: Guide for Beginners — RadioGraphics, 2025
Ultrasound Physics12%
50.How should frequency balance detail and penetration?
Higher-frequency ultrasound improves spatial detail but attenuates more rapidly, limiting penetration. Breast imaging uses a high-frequency linear transducer while adapting the operating frequency to depth and body habitus. Superficial targets benefit from fine detail, whereas a deep posterior target may require lower frequency. Select the highest frequency that adequately penetrates the region of interest and then optimize focus, gain, and positioning. The maximum available frequency is not automatically the most useful setting.
Apply it
Reduce operating frequency when a posterior boundary remains poorly penetrated despite suitable positioning and contact.
Common pitfall: Increasing gain does not reduce tissue attenuation. Unnecessarily low frequency sacrifices detail, while excessive frequency may conceal deep margins.
Equipment: Breast Ultrasound, revised January 2, 2026 · Breast US: Guide for Beginners — RadioGraphics, 2025
51.Why must gain be optimized before judging internal echoes?
Gain changes the displayed amplitude of received echoes rather than the tissue's composition. Excessive gain may create apparent echoes within fluid, while insufficient gain may conceal weak echoes or a tissue component. Time-gain compensation balances brightness at different depths. Before classifying a finding as anechoic or debris-containing, optimize the surrounding image and reassess the contents in complementary planes. A valid interpretation should remain supported under technically appropriate settings rather than depend on an artificially dark or bright image.
Apply it
Normalize an excessively bright examination before deciding whether faint echoes within a presumed cyst represent true contents.
Common pitfall: Turning gain down until a lesion appears black does not prove fluid and may hide clinically important solid tissue.
Breast US: Guide for Beginners — RadioGraphics, 2025 · Clinical Testing: Breast Ultrasound, revised March 13, 2026
52.How do depth and focus affect lesion assessment?
Set depth to include the target and sufficient posterior tissue for assessment without making the finding unnecessarily small. Place the focal region near the target to improve lateral detail where it matters. Poor focus can degrade boundary definition, while excessive depth reduces useful display size. Optimize acquisition before judging an indistinct margin or enlarging a stored image. Display magnification can improve viewing convenience but cannot recover information that was not resolved during the original acquisition.
Apply it
For a small superficial mass on an unnecessarily deep image, reduce depth and reposition focus before reassessing its margin.
Common pitfall: Electronic enlargement does not repair inadequate resolution. A technical boundary limitation should not automatically become a pathological descriptor.
Breast US: Guide for Beginners — RadioGraphics, 2025 · ACR Practice Parameter for the Performance of a Diagnostic Breast Ultrasound Examination, revised 2021
53.Why does fluid commonly produce posterior enhancement?
Fluid generally attenuates sound less than adjacent breast tissue, allowing relatively more energy to reach deeper structures. Echoes behind the fluid therefore appear brighter than those at similar depth beside it. This produces posterior enhancement. The feature commonly supports a simple cyst when the structural criteria also fit, but some solid findings can enhance. Enhancement describes relative sound transmission rather than histological benignity and does not replace evaluation of the wall, contents, shape, and margins.
Apply it
Compare tissue at the same depth beside and behind a lesion to identify enhancement before interpreting the lesion's composition.
Common pitfall: A bright posterior column does not override a solid component. Subtle enhancement alone should not exclude an otherwise qualifying simple cyst.
Ultrasound: Masses — UCLA Health · BI-RADS-Summary-Form-Ultrasound.pdf
54.How can angle changes identify edge shadowing?
Refraction at a curved interface can redirect sound away from the returning beam, creating narrow shadows at a lesion's edges. Supporting interfaces can also produce angle-dependent shadowing. Change probe angle and examine adjacent planes to determine whether the shadow moves, disappears, or remains associated with an actual abnormality. Current posterior-feature assessment disregards edge shadows when characterizing a mass's shadowing. Persistent central shadowing and structural distortion still require evaluation of the underlying tissue.
Apply it
For paired narrow shadows beside a rounded cyst, assess their relation to the curved wall before interpreting them as tissue extension.
Common pitfall: Do not include an acoustic edge effect in lesion dimensions or dismiss persistent abnormal tissue simply because some shadowing changes with angle.
Ultrasound: Masses — UCLA Health · BI-RADS-Summary-Form-Ultrasound.pdf
55.How can reverberation mimic internal material?
Reverberation occurs when sound reflects repeatedly between strong interfaces, producing additional echoes displayed at increasing apparent depths. Within a superficial fluid-containing finding, these echoes can imitate contents. Repetitive spacing and changes with angulation or contact support an artifact. Obtain alternative views and optimize technique before describing a solid component. A genuine attached component should be assessed for reproducible structural attachment and perfusion rather than inferred from one image containing repeated superficial echoes.
Apply it
When parallel echoes change markedly with probe angulation, reassess the apparent contents in complementary views before calling a mural nodule.
Common pitfall: Not every internal echo is artifact. A persistent attached structure still requires evaluation even when reverberation is present elsewhere.
Breast Sonography Examination Content Outline, Version 24.1 · ACR Practice Parameter for the Performance of a Diagnostic Breast Ultrasound Examination, revised 2021
56.How can Doppler technique prevent false absence of flow?
Excessive pressure can compress small vessels and suppress their flow signal. Lighten contact and adjust scale, wall filter, gain, and the Doppler region for the expected velocities. High scale or wall-filter settings can remove slow-flow information, while excessive gain or motion can create false color. Confirm that signal is reproducible within the structure rather than arising from movement. An absent-flow description should follow technically appropriate assessment and still acknowledge the sensitivity limits of Doppler.
Apply it
Reassess a small nodule with lighter contact and slow-flow settings before interpreting its initial lack of color as meaningful.
Common pitfall: No displayed color does not establish benignity. Switching Doppler modes without correcting vessel compression can leave the principal limitation unresolved.
ACR Practice Parameter for the Performance of a Diagnostic Breast Ultrasound Examination, revised 2021 · Breast Sonography Examination Content Outline, Version 24.1
Emerging Technology and Treatment7%
57.What does elastography add to grayscale ultrasound?
Elastography estimates tissue stiffness, a property distinct from echogenicity and blood flow. Hard findings tend to be more concerning and soft findings tend to be benign, but exceptions occur in both directions. The current ACR summary emphasizes morphology as more important than stiffness. Integrate elasticity with lesion structure, acquisition quality, and clinical context. A relatively soft result cannot independently cancel persistent angular margins, a suspicious tissue pattern, or an unresolved clinical-imaging discrepancy.
Apply it
Retain suspicious grayscale morphology when a mass appears soft on technically adequate elastography.
Common pitfall: Stiffness is not a tissue diagnosis. Fibrosis may be stiff, and relative softness does not guarantee benignity.
Elastography — RadiologyInfo · BI-RADS-Summary-Form-Ultrasound.pdf
58.How do automated and three-dimensional ultrasound complement targeted scanning?
Automated whole-breast ultrasound acquires broad tissue volumes, while three-dimensional imaging permits assessment in reconstructed planes. These approaches support coverage and spatial understanding but depend on adequate contact, acquisition, and interpretation. A detected finding may require targeted handheld ultrasound for focused morphology, Doppler, symptom correlation, or procedural planning. Volumetric acquisitions should show a mass in three planes. Ultrasound remains complementary to mammography, especially because calcification morphology requires mammographic correlation rather than reliance on volume coverage alone.
Apply it
Confirm an abnormality near the edge of an automated acquisition with targeted imaging and assess whether poor contact contributed.
Common pitfall: A reconstructed volume does not prove complete diagnostic evaluation. Coverage gaps and artifacts can still require focused reassessment.
Breast Ultrasound — RadiologyInfo · Breast Sonography Examination Content Outline, Version 24.1 · BI-RADS-Summary-Form-Ultrasound.pdf
59.How do treatment details guide follow-up imaging?
Adjuvant therapy describes additional treatment after primary treatment intended to reduce recurrence risk. Brachytherapy describes radiation delivered from a source placed within or near the treatment target. Timing and delivery method therefore answer different questions. Follow-up interpretation requires the treatment type, location, dates, operative details, and prior imaging. Established postoperative collections, scar, and post-treatment skin or trabecular thickening can affect appearance, but a new discrete mass or progressive unexplained finding requires its own characterization.
Apply it
Compare a treated breast's cavity and skin findings with the treatment history and prior studies before attributing a new change to therapy.
Common pitfall: Previously treated is too imprecise to explain an abnormality. Treatment history does not automatically establish that a new mass is expected.
Breast Sonography Examination Content Outline, Version 24.1 · Post-Surgical Fluid Collections: Causes, Symptoms, and Management — UCLA Health · BIRADS-v2025-Whats-New.pdf
60.How do sampling, specimen imaging, and sentinel mapping differ?
Fine-needle aspiration withdraws fluid or cells, whereas core biopsy obtains tissue for histological examination. Procedural ultrasound documents the target and sampling device in relation to it; a solid component must be evaluated directly rather than assumed sampled through fluid aspiration. Specimen imaging addresses whether removed material contains the intended imaging target. Sentinel-node mapping identifies first-draining nodes: radiotracer, blue dye, or both travel through lymphatics to nodes that are detected, removed, and examined for cancer.
Apply it
Distinguish ultrasound assessment of nodal morphology from tracer-based identification of sentinel nodes, and document the relevant target during breast sampling.
Common pitfall: The largest visible node is not necessarily sentinel. A visible needle shaft or marker alone does not prove representative tissue acquisition.
Ultrasound-Guided Breast Biopsy — RadiologyInfo · Sentinel Lymph Node Biopsy - NCI · Breast Sonography Examination Content Outline, Version 24.1
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Give pathology the largest share of study time: distinguish simple fluid, debris, solid components, suspicious morphology, infection, implant complications, and postoperative findings.
- Connect BI-RADS risk boundaries with management, especially category 3 surveillance, category 4 tissue diagnosis, and category 5 suspicion versus category 6 established malignancy.
- Prove that palpable, mammographic, MRI, ultrasound, and biopsy findings represent the same target.
- Connect acoustic and Doppler observations to their mechanisms and to useful technical adjustments.
- Use reproducible planes, measurements, clockface locations, and nipple distances to support comparison and intervention.
- Separate imaging probability from microscopic diagnosis and benign pathology from a concordant benign result.
- Review every task in the official outline, which defines the full examination scope beyond this selective guide.
A practical preparation plan
1. Build a domain checklist
Use the official outline to list every domain and detailed task. Identify tasks covered here and those requiring additional study.
2. Compare morphology systematically
Describe shape, margin, orientation, echo pattern, posterior features, and associated changes before interpreting a finding. Contrast simple cysts, complicated cysts, mixed solid and cystic masses, and solid masses.
3. Connect assessment with action
Use integrated findings to distinguish benign, probably benign, suspicious, highly suggestive, and biopsy-proven malignant assessments. Explain the management consequence of each category.
4. Practise technical corrections
Identify the limiting mechanism before changing settings: improve positioning for access, frequency for penetration, gain for contents, contact for superficial targets, and pressure or Doppler settings for flow.
5. Follow the target across modalities
Work through mammography-to-ultrasound, MRI-to-ultrasound, palpable-to-imaging, and imaging-to-pathology cases. State what establishes correspondence and which discrepancy remains unresolved.
6. Explain every alternative
Answer the questions without notes, then explain why each alternative fits or fails. Use flashcards for mechanisms and decision boundaries, and complete remaining official outline tasks with additional study.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- Breast (BR) — Inteleos
- Breast Sonography Examination Content Outline, Version 24.1
- Breast Examination Content Outline, Version 26.1
- ACR Practice Parameter for the Performance of a Diagnostic Breast Ultrasound Examination, revised 2021
- Clinical Testing: Breast Ultrasound, revised March 13, 2026
- Equipment: Breast Ultrasound, revised January 2, 2026
- Quality Assurance: Breast Ultrasound, revised November 18, 2024
- What Is Breast Cancer? — National Cancer Institute
- Breast Anatomy — NCI SEER Training
- Benign and Precancerous Breast Lumps and Conditions — National Cancer Institute
- Basics of Breast Ultrasound — UCLA Health
- Axillary Lymphadenopathy — UCLA Health
- Ultrasound: Masses — UCLA Health
- Post-Surgical Fluid Collections: Causes, Symptoms, and Management — UCLA Health
- Mammography: Male Mammography — UCLA Health
- Ultrasound: Calcifications — UCLA Health
- Cystic Lesions of the Breast: Sonographic-Pathologic Correlation — Radiology, 2003
- Breast US: Guide for Beginners — RadioGraphics, 2025
- Ultrasound-Guided Breast Biopsy — RadiologyInfo
- MR-Guided Breast Biopsy — RadiologyInfo
- Elastography — RadiologyInfo
- Breast Ultrasound — RadiologyInfo
- Risks and Complications of Breast Implants — FDA
- Palpable Lump — UCLA Health
- BI-RADS v2025 Is Your Definitive Guide to Breast Imaging — ACR
- Sentinel Lymph Node Biopsy - NCI
- ACR Breast Imaging Reporting & Data System (BI-RADS®)
- BIRADS-v2025-Whats-New.pdf
- BI-RADS-Summary-Form-Ultrasound.pdf
- asbrs-ccs-image-guided-biopsy.pdf
- Brachytherapy for Cancer - NCI
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.